Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY: XLV )

144.80 -1.59 (-1.09%)
Official Closing Price Updated: 8:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
26 27 Next >
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
Via Talk Markets
Health Care Workers Underpin US Jobs Growth In February
Hospitals and outpatient care account for bulk of health sector jobs. 
Via Benzinga
S&P 500 Index Closes At Record Heights, Reaches Most Overbought Conditions Since January 2020
S&P 500 index at 5,171 points, up 1% and hitting new highs. Week's rally is 17th in 19 weeks, with strong breadth and diverse sector performance. 
Via Benzinga
Topics Stocks
Exposures US Equities
XLV Made Reaction From The Blue Box
XLV is giving us wave (2) pull back that is unfolding as Double Three pattern. Pull back has already reached extreme zone from the peak. 
Via Talk Markets
bluebird bio Stock Signals Potential to be a Multi-bagger
Driving a bargain of a short squeeze play, Bluebird Bio stock could soon announce what every investor is hoping to hear, here's what management could do 
Via MarketBeat
Topics Economy
Exposures Economy
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
Hedge funds are shifting towards stability and value by favoring the health care sector over booming tech stocks. 
Via Benzinga
Communications, Health Sectors Lead Rally In US Stocks In 2024
The strong year-to-date gain in the US stock market is broad based, led by shares in communications services and health care, based on a set of sector ETFs. 
Via Talk Markets
bluebird bio stock is ripe for a 400% institutional short squeeze
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Weekly Market Pulse: Artificial Intelligence?
The AI boom has pushed the stock market into one of its periodic flights of fancy when the future seems certain and imminent. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts
After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday reflects edginess. 
Via Benzinga
Topics Stocks
Exposures US Equities
Top ETFs for Every Sector
Top ETFs for all 11 S&P 500 sectors. 
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
Healthcare Stocks Are Looking Better But What About Biotech?
Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing. 
Via Talk Markets
Health Care Select Sector XLV Found Buyers At The Blue Box Area As Expected
In today’s article, we will look at the past performance of the one-hour chart for the Health Care Select Sector ETF XLV. The rally from the Jan. 25 low at $137.21 unfolded as a 5-wave impulse. 
Via Talk Markets
Topics ETFs
Four Charts Every Trader Needs To See Today
As I’ve noted previously, the S&P 500 is quite extended above both its 10-week moving average (same as the 50-DMA) as well as the 40-week moving average (same as the 200-DMA). 
Via Talk Markets
Topics Stocks
Exposures US Equities
Market Correction Due: Stocks Are Running Out Of Reasons To Move Higher, Analyst Says
Stocks running out of reasons to move higher, market correction imminent. Internal indicators signal sell, could take S&P 500 back to 4,600. 
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500 rockets to new highs as earnings beat estimates
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders. 
Via MarketBeat
Topics ETFs Earnings Stocks
Exposures Financial US Equities
Can financial, healthcare, energy stocks rise as rates stay high?
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024. 
Via MarketBeat
3 Sector ETFs & Stocks To Bet On Superb January Jobs Data
In this article, we have highlighted some of the sectors that will likely see smooth trading in the days ahead in light of the January jobs data 
Via Talk Markets
Topics ETFs
Forget Rate Cuts, Buy Top-Ranked Sector ETFs
Uncertainty surrounding the timing of rate cuts has been playing foul on the stock market this year. 
Via Talk Markets
Healthcare And Life Science Funds And ETFs Performance 2023-2024
Healthcare stocks usually provide a defensive posture to a stock portfolio. 
Via Talk Markets
Topics ETFs
Markets suddenly price Eli Lilly stock for a breakout on earnings
The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Interest Rates
US Stocks Rise At Week's Start, Tesla Rebounds, SoFi, Lucid Shine: What's Driving Markets Monday?
Wall Street witnessed slight gains at midday on Monday, with investors eagerly awaiting a series of critical earnings reports, the Federal Reserve’s meeting on Wednesday and the much-anticipated job... 
Via Benzinga
Pfizer’s earnings growth trade at a deep discount, suddenly a buy
The healthcare sector is set to attract a new inflow of investment dollars, as seen in business activity and employment. Pfizer is the clear sector favorite 
Via MarketBeat
Topics Economy
Exposures Economy
Just What Powers The SPY
The S&P 500 closed the week below fresh highs thanks to a bout in tech and relative weakness in some semiconductors. The rally is broadening, though, with XLI and XLV appearing to be well-positioned. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Stocks Ease Despite Benign Inflation Data, Bitcoin Stages Comeback: What's Driving Markets Friday?
Stocks mixed in New York, with investors assessing mild inflation report and strong personal spending figures. Short-term Treasury yields rise, tech stocks lag, and Bitcoin surges 4.9%. Intel stock... 
Via Benzinga
Topics Economy
Exposures Interest Rates
5 top healthcare stocks for earnings growth in 2024
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. 
Via MarketBeat
Baby Bust: Will Falling Global Birth Rates Drive Markets Lower?
In the U.S., the birth rate is still growing, but at a much slower rate since the global financial crisis in 2008. 
Via Benzinga
Weekly Market Pulse: Is The Recession Finally Here?
You need to sell when things look great – but not too soon – and buy when things look awful – but not too soon. 
Via Talk Markets
Topics Economy
Exposures Economy
Pfizer, Autodesk, AbbVie And More: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund (NYSE: XLV) 
Via Benzinga
Did Today's Volume Signal New Record Highs Ahead Of Sentiment
An analysis of the major indexes' movement on higher than average volume. 
Via Talk Markets
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.